Glucose Priming Could Enhance Tumor Targeting of Chemotherapy Nanocarriers

This research explores the use of glucose priming to improve the targeting of chemotherapy nanocarriers to tumors. Current pH-sensitive nanocarriers rely on tumor acidity for drug release but face challenges due to the modest and uneven pH gradient in tumors. The study suggests glucose priming may offer a more effective approach to increase chemotherapy selectivity and reduce systemic toxicity.

Originally published by gnews